Physician profile
Mark J Van Ess
NPI 1841404613
$948.43
in general payments reported to CMS, 2019-2025
8 companies · $594 in 2025
The $594 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.50 · 2021: $79.33 · 2022: $13.95 · 2024: $242 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $317.14 | 2024-2025 | Matrixmidface, Matrixrib |
| Ethicon US, LLC | $144.41 | 2025 | Ethicon, Surgicel Nu-Knit, Vistaseal |
| Stryker Corporation | $126.49 | 2019-2025 | Na |
| Smith+Nephew, INC. | $102.71 | 2024-2025 | Coblation, Tula, Halo |
| Integra Lifesciences Corporation | $91.33 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Medtronic, INC. | $73.35 | 2025 | Pteye Parathyroid Detection System |
| Advanced Bionics, LLC | $65.55 | 2021 | |
| Cochlear Americas | $27.45 | 2022-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Van Ess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.